Atlas Trials

First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss

Clinical trial NCT07637981 · RECRUITING

Trial details

NCT number
NCT07637981
Sponsor
Dendrogenix
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Age-related Hearing Loss
Start date
2026-05-13
Primary completion
2027-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.